David Claxton

Professor David Claxton is affiliated with the Department of Medicine at Penn State University, specializing in Hematology and Oncology. His research focuses on acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and hematopoietic stem cell transplantation.

• Active in leukemia molecular genetics and clinical supportive care
• Principal investigator on grants from the National Cancer Institute and National Center for Research Resources

Research trends include sphingolipid metabolism in AML, long non-coding RNA mechanisms, and innovative preconditioning strategies for allogeneic transplants.

Scientific Recognition:

• Awarded Outstanding Collaborative Research Team (2015) for interdisciplinary leukemia research

Laboratory Resources: Maintains a viable biobank of human leukemia and lymphoma samples for collaborative studies and xenograft models.